<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39450400</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2328-8957</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Open forum infectious diseases</Title><ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Impact of the COVID-19 Pandemic on Group A Streptococcal Necrotizing Soft Tissue Infections: A Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>ofae572</StartPage><MedlinePgn>ofae572</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ofae572</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofae572</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Necrotizing soft tissue infections (NSTIs) are often caused by group A <i>Streptococcus</i> (GAS). As the number of invasive GAS infections decreased during the coronavirus disease 2019 (COVID-19) pandemic restrictions, this study aimed to compare the occurrence of GAS-NSTIs before, during, and after the COVID-19 pandemic restrictions.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This retrospective cohort study included adult patients with NSTIs admitted to the intensive care unit (ICU) of the University Hospital Zurich, Switzerland, from July 2008 to December 2023. NSTI cases were categorized as pre-, during, and postrestrictions. The primary outcome was the proportion of GAS in NSTI, and the exploratory secondary outcome was in-hospital death. A data analysis was conducted using Firth logistic regression adjusted for age, sex, diabetes, and initially affected body region.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Overall, 74 NSTI cases were identified, with 49 occurring before, 8 during, and 17 after the pandemic restrictions. GAS was isolated in 27 (36%) cases, with 17 (35%) pre- and 10 (59%) postrestrictions, but none during the restrictions. NSTIs caused by other bacteria persisted during the restrictions. The odds of GAS were significantly lower during the restrictions (adjusted odds ratio, 0.02; 95% CI, 0.001-0.81) compared with after, while no significant differences were found between the pre- and postrestriction periods.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The significant decrease of GAS-NSTIs during the COVID-19 pandemic restrictions suggests that isolation measures may have prevented the transmission of GAS, resulting in a decline of GAS-NSTIs while NSTIs caused by bacteria transmitted by alternative routes persisted.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Epprecht</LastName><ForeName>Gioia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weller</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofmaenner</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-9334-7753</Identifier><AffiliationInfo><Affiliation>Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrianaki</LastName><ForeName>Angeliki M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-2399-1946</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frey</LastName><ForeName>Pascal M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0001-6161-0919</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Internal Medicine, Bern University Hospital (Inselspital), Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brugger</LastName><ForeName>Silvio D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0001-9492-9088</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinkernagel</LastName><ForeName>Annelies S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0003-4700-1118</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Open Forum Infect Dis</MedlineTA><NlmUniqueID>101637045</NlmUniqueID><ISSNLinking>2328-8957</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">group A Streptococcus</Keyword><Keyword MajorTopicYN="N">isolation measures</Keyword><Keyword MajorTopicYN="N">necrotizing soft tissue infections</Keyword></KeywordList><CoiStatement>Potential conflicts of interest. All authors: no reported conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>4</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39450400</ArticleId><ArticleId IdType="pmc">PMC11500445</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofae572</ArticleId><ArticleId IdType="pii">ofae572</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hua  C, Urbina  T, Bosc  R, et al.  Necrotising soft-tissue infections. Lancet Infect Dis  2023; 23:e81–94.</Citation><ArticleIdList><ArticleId IdType="pubmed">36252579</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens  DL, Bryant  AE, Goldstein  EJ. Necrotizing soft tissue infections. Infect Dis Clin North Am  2021; 35:135–55.</Citation><ArticleIdList><ArticleId IdType="pubmed">33303335</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchiyama  S, Andreoni  F, Zurcher  C, et al.  Coiled-coil irregularities of the M1 protein structure promote M1-fibrinogen interaction and influence group A Streptococcus host cell interactions and virulence. J Mol Med (Berl)  2013; 91:861–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3695690</ArticleId><ArticleId IdType="pubmed">23443671</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinkernagel  AS, Timmer  AM, Pence  MA, et al.  The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe  2008; 4:170–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631432</ArticleId><ArticleId IdType="pubmed">18692776</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization . Increased Incidence of Scarlet Fever and Invasive Group A Streptococcus Infection—Multi-country. World Health Organization; 2022. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON429. Accessed January 16, 2024.</Citation></Reference><Reference><Citation>Ho  EC, Cataldi  JR, Silveira  LJ, et al.  Outbreak of invasive group A Streptococcus in children—Colorado, October 2022-April 2023. J Pediatric Infect Dis Soc  2023; 12:540–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">37792995</ArticleId></ArticleIdList></Reference><Reference><Citation>Peetermans  M, Matheeussen  V, Moerman  C, et al.  Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series. Ann Intensive Care  2024; 14:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10825083</ArticleId><ArticleId IdType="pubmed">38286885</ArticleId></ArticleIdList></Reference><Reference><Citation>Mettias  B, Jenkins  D, Rea  P. Ten-year prevalence of acute hospital ENT infections and the impact of COVID: a large population study. Clin Otolaryngol  2023; 48:10–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538811</ArticleId><ArticleId IdType="pubmed">36068673</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw  D, Abad  R, Amin-Chowdhury  Z, et al.  Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium. Lancet Digit Health  2023; 5:e582–93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10914672</ArticleId><ArticleId IdType="pubmed">37516557</ArticleId></ArticleIdList></Reference><Reference><Citation>
Verordnung vom 28 . Februar 2020 über Massnahmen zur Bekämpfung des Coronavirus (COVID-19) der Schweizerische Bundesrat 2020. 2020. Available at: https://www.fedlex.admin.ch/eli/cc/2020/107/de. Accessed January 25, 2024.</Citation></Reference><Reference><Citation>Coronavirus: Rückkehr in die normale Lage und Planung der Übergangsphase bis Frühling 2023 der Schweizerische Bundesrat 2022. 2022. Available at: https://www.admin.ch/gov/de/start/dokumentation/medienmitteilungen.msg-id-87801.html. Accessed January 25, 2024.</Citation></Reference><Reference><Citation>Hofmaenner  DA, Wendel Garcia  PD, Blum  MR, et al.  The importance of intravenous immunoglobulin treatment in critically ill patients with necrotizing soft tissue infection: a retrospective cohort study. BMC Infect Dis  2022; 22:168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862556</ArticleId><ArticleId IdType="pubmed">35189821</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson  ME, Pompei  P, Ales  KL, MacKenzie  CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis  1987; 40:373–83.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong  CH, Khin  LW, Heng  KS, Tan  KC, Low  CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med  2004; 32:1535–41.</Citation><ArticleIdList><ArticleId IdType="pubmed">15241098</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruun  T, Kittang  BR, de Hoog  BJ, et al.  Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway. Clin Microbiol Infect  2013; 19:E545–50.</Citation><ArticleIdList><ArticleId IdType="pubmed">23795951</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen  IC, Li  WC, Hong  YC, Shie  SS, Fann  WC, Hsiao  CT. The microbiological profile and presence of bloodstream infection influence mortality rates in necrotizing fasciitis. Crit Care  2011; 15:R152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219026</ArticleId><ArticleId IdType="pubmed">21693053</ArticleId></ArticleIdList></Reference><Reference><Citation>Das  DK, Baker  MG, Venugopal  K. Risk factors, microbiological findings and outcomes of necrotizing fasciitis in New Zealand: a retrospective chart review. BMC Infect Dis  2012; 12:348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3538518</ArticleId><ArticleId IdType="pubmed">23234429</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawijn  F, de Gier  B, Brandwagt  DAH, Groenwold  RHH, Keizer  J, Hietbrink  F. Incidence and mortality of necrotizing fasciitis in The Netherlands: the impact of group A Streptococcus. BMC Infect Dis  2021; 21:1217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8650531</ArticleId><ArticleId IdType="pubmed">34872527</ArticleId></ArticleIdList></Reference><Reference><Citation>Friederichs  J, Gerl  B, Schneidmuller  D, Hungerer  S. Severe necrotizing soft tissue infections—is wound microbiology a prognostic factor for clinical outcome?  Int Wound J  2023; 20:4235–43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10681420</ArticleId><ArticleId IdType="pubmed">37646330</ArticleId></ArticleIdList></Reference><Reference><Citation>Breidung  D, Billner  M, Megas  IF, Edo  AM, Reichert  B, Malsagova  AT. Increase in streptococcal necrotizing fasciitis during and after the coronavirus disease 2019 pandemic. Surg Infect (Larchmt)  2024; 25:169–74.</Citation><ArticleIdList><ArticleId IdType="pubmed">38324002</ArticleId></ArticleIdList></Reference><Reference><Citation>Marco  DN, Canela  J, Brey  M, Soriano  A, Pitart  C, Herrera  S. Assessing the influence of the COVID-19 pandemic on the incidence, clinical presentation, and clindamycin resistance rates of Streptococcus pyogenes infections. IJID Reg  2024; 11:100349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10973571</ArticleId><ArticleId IdType="pubmed">38558547</ArticleId></ArticleIdList></Reference><Reference><Citation>Guy  R, Henderson  KL, Coelho  J, et al.  Increase in invasive group A streptococcal infection notifications, England, 2022. Euro Surveill  2023; 28:2200942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9817207</ArticleId><ArticleId IdType="pubmed">36695450</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcolea-Medina  A, Snell  LB, Alder  C, et al.  The ongoing Streptococcus pyogenes (group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology study. Clin Microbiol Infect  2023; 29:887–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10769882</ArticleId><ArticleId IdType="pubmed">36925107</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrianaki  AM, Franz  J, Andreoni  F, et al.  Molecular epidemiology of invasive group A streptococcal infections before and after the COVID-19 pandemic in Switzerland. CMI Comm  2024; 1. 10.1016/j.cmicom.2024.100004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmicom.2024.100004</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherardi  G, Vitali  LA, Creti  R. Prevalent emm types among invasive GAS in Europe and North America since year 2000. Front Public Health  2018; 6:59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5890186</ArticleId><ArticleId IdType="pubmed">29662874</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira  A, Wan  Y, Ryan  Y, et al.  Rapid expansion and international spread of M1(UK) in the post-pandemic UK upsurge of Streptococcus pyogenes. Nat Commun  2024; 15:3916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11087535</ArticleId><ArticleId IdType="pubmed">38729927</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacey  JA, Marcato  AJ, Chisholm  RH, et al.  Evaluating the role of asymptomatic throat carriage of Streptococcus pyogenes in impetigo transmission in remote aboriginal communities in Northern Territory, Australia: a retrospective genomic analysis. Lancet Microbe  2023; 4:e524–33.</Citation><ArticleIdList><ArticleId IdType="pubmed">37211022</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingsworth  B, Okamoto  KW, Lloyd  AL. After the honeymoon, the divorce: unexpected outcomes of disease control measures against endemic infections. PLoS Comput Biol  2020; 16:e1008292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595641</ArticleId><ArticleId IdType="pubmed">33075052</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes  M, Youngkin  E, Zipprich  J, et al.  Notes from the field: increase in pediatric invasive group A Streptococcus infections—Colorado and Minnesota, October-December 2022. MMWR Morb Mortal Wkly Rep  2023; 72:265–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10010751</ArticleId><ArticleId IdType="pubmed">36893049</ArticleId></ArticleIdList></Reference><Reference><Citation>Fourgeaud  J, Toubiana  J, Chappuy  H, et al.  Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France. Eur J Clin Microbiol Infect Dis  2021; 40:2389–95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8331994</ArticleId><ArticleId IdType="pubmed">34347190</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatter  L, Eathorne  A, Hills  T, Bruce  P, Beasley  R. Respiratory syncytial virus: paying the immunity debt with interest. Lancet Child Adolesc Health  2021; 5:e44–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8598182</ArticleId><ArticleId IdType="pubmed">34695374</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera  AL, Huber  VC, Chaussee  MS. The association between invasive group A streptococcal diseases and viral respiratory tract infections. Front Microbiol  2016; 7:342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800185</ArticleId><ArticleId IdType="pubmed">27047460</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi  B, Sudry  T, Flaks-Manov  N, et al.  Long COVID outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ  2023; 380:e072529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Feeney  G, Hannan  E, Fallon  J, et al.  Necrotising fasciitis in the COVID-19 era: a consequence of caution—a case series. Int J Surg Open  2022; 43:100488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9093097</ArticleId><ArticleId IdType="pubmed">35578663</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>